[Golden Biotechnology] Announcement of Board of Directors' Resolution to Issue Restricted Stock Units to Employees
NQ Score
100/100
AI Summary (NQ-processed)
Golden Biotechnology's board of directors resolved on April 8, 2026, to issue restricted stock units to employees, with a maximum of 1,000,000 common shares and an issuance price of NT$0. This initiative aims to attract and retain professional talent, and to motivate employees to enhance loyalty and productivity. Employees must meet vesting conditions, including continued employment, company operational goals, and individual performance indicators, to receive shares proportionally. The estimated expensed amount for this plan is approximately NT$83,000 thousand, which may dilute earnings per share.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: When did Golden Biotechnology's board of directors resolve to issue restricted stock units to employees?
- A: Golden Biotechnology's board of directors resolved to issue restricted stock units on April 8, 2026.
- Q: What is the expected issuance price for the restricted stock units offered by Golden Biotechnology?
- A: The restricted stock units are issued gratuitously to employees, with an issuance price of NT$0.
- Q: How many common shares may be issued by Golden Biotechnology under this restricted stock unit plan?
- A: Golden Biotechnology may issue up to 1,000,000 common shares under the restricted stock unit plan.
- Q: What are the vesting conditions based on years of service for employees receiving restricted stock units?
- A: Employees may vest 20% after one year, 30% after two years, and 50% after three years of continued employment.
- Q: What company operational goals must Golden Biotechnology meet for employees to vest their restricted stock units?
- A: Golden Biotechnology must achieve drug approval, sign international licensing agreements with payment, or grow operating revenue or pre-tax net income by 100% year-on-year.